The “YOUNG” study

The research programme focuses on early-onset breast cancer, with particular attention to patients younger than 40 years without pathogenic germline mutations in BRCA1/2. The project aims to investigate the role of functional homologous recombination deficiency (HRD), assessed through the RAD51 functional assay, in identifying alterations in DNA repair mechanisms.